Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vedolizumab”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableAvailableNCT06856135
What this trial is testing

Expanded Access to Vedolizumab for Children and Teenagers With Ulcerative Colitis or Crohn's Disease in the USA

Who this might be right for
Crohn's DiseaseUlcerative Colitis
Takeda
Post-approval studies (Phase 4)Study completedNCT02559713
What this trial is testing

Postmarketing Vedolizumab Milk-Only Lactation Study in Lactating Women With Active Ulcerative Colitis or Crohn's Disease

Who this might be right for
Colitis, UlcerativeCrohn's Disease
Takeda 11
Early research (Phase 1)Study completedNCT06732804
What this trial is testing

Study to Investigate Comparative Pharmacokinetics, Safety, Immunogenicity and Tolerability Between AVT80 and Entyvio

Who this might be right for
Healthy Male and Female Subjects
Alvotech Swiss AG 385
Testing effectiveness (Phase 2)Looking for participantsNCT06850727
What this trial is testing

Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)UC - Ulcerative Colitis
Odyssey Therapeutics 57
Very early researchStudy completedNCT05281614
What this trial is testing

Immune Effects of Vedolizumab With or Without Anti-TNF Pre-treatment in T1D

Who this might be right for
Type 1 Diabetes
Benaroya Research Institute 20
Post-approval studies (Phase 4)Study completedNCT02630966
What this trial is testing

Vedolizumab IV 300 mg in the Treatment of Fistulizing Crohn's Disease

Who this might be right for
Crohn's Disease
Takeda 34
Not applicableEnded earlyNCT03802214
What this trial is testing

Ulcerative Colitis - Vedolizumab- With/Without Prior Exposure to Anti-TNF（Tumor Necrosis Factor）Therapy

Who this might be right for
Ulcerative Colitis
Stanford University 1
Not applicableLooking for participantsNCT06954311
What this trial is testing

Therapeutic Drug Monitoring for Biological Therapy in Pediatric Inflammatory Bowel Disease

Who this might be right for
Ulcerative Colitis (UC)IBD-unclassified (IBD-U)
Medical University Innsbruck 120
Post-approval studies (Phase 4)WithdrawnNCT02760615
What this trial is testing

Phase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction Study

Who this might be right for
Colitis, UlcerativeCrohn Disease
Takeda
Testing effectiveness (Phase 2)Study completedNCT04120415
What this trial is testing

A HIV Vaccine Trial in Individuals Who Started Antiretrovirals During Primary or Chronic Infection (EHVA T02)

Who this might be right for
HIV-1-infection
ANRS, Emerging Infectious Diseases 2
Large-scale testing (Phase 3)UnknownNCT04919252
What this trial is testing

Efficacy and Safety of Vedolizumab in Biologic-naïve Korean Patients With Moderate to Severe Inflammatory Bowel Disease

Who this might be right for
Crohn's Disease and Ulcerative Colitis
Yonsei University 60
Not applicableStudy completedNCT02678052
What this trial is testing

OTIS Vedolizumab Pregnancy Exposure Registry

Who this might be right for
Colitis, UlcerativeCrohn's Disease
Takeda 303
Post-approval studies (Phase 4)Looking for participantsNCT06584162
What this trial is testing

Subcutaneous Interval Lengthening of Vedolizumab for Economic Research

Who this might be right for
Inflammatory Bowel Diseases
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 40
Large-scale testing (Phase 3)WithdrawnNCT04469062
What this trial is testing

Mirikizumab (LY3074828) in Participants With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Eli Lilly and Company
Large-scale testing (Phase 3)Ended earlyNCT04064697
What this trial is testing

Impact of Anti-cytomegalovirus Treatment in the Management of Relapsing Ulcerative Colitis Requiring Vedolizumab Therapy

Who this might be right for
Ulcerative Colitis, Unspecified
Centre Hospitalier Universitaire de Saint Etienne 6
Not applicableUnknownNCT03889613
What this trial is testing

Pillcam Crohn's Capsule for Monitoring of Panenteric Mucosal Healing in Crohn's Disease Patients With Vedolizumab

Who this might be right for
Crohn Disease
Sheba Medical Center 60
Early research (Phase 1)Study completedNCT02788175
What this trial is testing

Vedolizumab (Anti-alpha4beta7) in Subjects With HIV Infection Undergoing Analytical Treatment Interruption

Who this might be right for
HIV
National Institute of Allergy and Infectious Diseases (NIAID) 26
Not applicableLooking for participantsNCT04331639
What this trial is testing

High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy

Who this might be right for
Inflammatory Bowel DiseaseCrohn DiseaseUlcerative Colitis+1 more
Boston Children's Hospital 50
Large-scale testing (Phase 3)Looking for participantsNCT06337695
What this trial is testing

Vedolizumab for the Prevention of ICI Related Diarrhea or Colitis in Patients With Cancer

Who this might be right for
IrAEImmune-related Adverse EventDiarrhea+1 more
AHS Cancer Control Alberta 36
Testing effectiveness (Phase 2)Study completedNCT01177228
What this trial is testing

Study of Vedolizumab Following Multiple Intravenous Doses in Patients With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Millennium Pharmaceuticals, Inc. 47
Next Page